Intravenous Ozone Methods Coming Soon
Ozone can be therapeutically administered to the human body in a number of ways. Intravenous Ozone therapies is where the patient’s blood is drawn, saturated with a meticulously controlled dose of ozone, and reintroduced to the body. This delivery method is regarded to be the most potent and effective healing modality utilizing ozone in a clinical environment, and often provides the most dramatic results. Clinical experience regarding Intravenous Ozone shows excellent success for treating a wide range of chronic health conditions, which conventional medicine often find notoriously difficult to handle. The IV Ozone therapies we practice are Major Autohemotherapy (MAH), Hyperbaric ‘10 pass’ Ozone, and HiDose O3.
Major Autohemotherapy (MAH)
For many years Major Autohemotherapy (MAH) was one of the most effective ways for systemically introducing medical Ozone into the body. This is a procedure that is practiced by medical doctors all around the world, and is sometimes seen in North American naturopathic clinics.
(MAH) involves intravenously withdrawing about 200ml of blood from the patient into an IV bag. The patient’s blood is then mixed with around 3000ug of ozone gas, by injecting the gas into the IV bag, and gently turning the bag over until the blood is saturated. After the patient’s blood has been mixed with the Ozone the IV bag is suspended, the same as in regular IV therapy, and gravity is utilized to have the ozonated blood drip back into the patient intravenously.
Major Autohemotherapy (MAH) is an effective therapy for systemically delivering Ozone to the body and for quite some time was one of the best ways of doing so. One of its drawbacks is that sometimes for chronically ill patients to truly reap the benefits of this therapy, multiple treatments are often required per week, since a limited amount of ozone is receive during each session. Treatments can be suggested as many as 5 times per week with each session costing several hundred dollars. This unfortunately can make receiving the benefits of systemic ozone therapy inconvenient and elusive to patients who cannot afford it. This is not to say Traditional MAH therapy is not an effective or useful ozone treatment. Many individuals see great benefits from receiving just a few MAH sessions, and the concentrations of Ozone delivered to the body are extremely therapeutic. However, there are conditions which seem to further benefit from more intensive Intravenous Ozone Treatments. Sometimes patient response to MAH therapy can be used to determine whether an individual should receive Higher Dose intravenous treatments.
Hyperbaric Ozone Therapy (High Dose ’10 Pass’)
The new Hyperbaric Ozone Therapy (High Dose ’10 Pass’) has been able to make up for some of the clinical shortcomings of MAH therapy. It is similar to MAH in that blood is drawn from the patient, but is more intensive; using higher concentrations of ozone on larger volumes of blood. It is an efficacious treatment that can safely administer much higher doses of ozone at a more reasonable price, considering the amount of Ozone the patient is able to receive per session.
Hyperbaric Ozone Therapy (High Dose ‘10 Pass’) resembles Major Autohemotherapy (MAH) but has some fundamental differences in potency and effectiveness. In both MAH and 10-pass ozone, blood is drawn from the patient and combined with ozone, which has the effect of killing microbes and cleansing the blood. The patient’s ozone infused blood is then reinjected intravenously. The MAH method tends to draw about 200-250 ml of blood and infuses this blood with roughly 3,000ug of ozone. With Hyperbaric Ozone Therapy the blood-draw infusion process is done ten times; hence the term “10-pass” and usually take 1-2 hours to complete. One 10-pass treatment is about the equivalent of 10 MAH treatments when comparing the amount of blood being treated, however this can be misleading since the 10-pass treatment actually uses much higher concentrations of Ozone on the blood. The 10-pass method mixes the patient’s blood with the ozone in a pressurized hyperbaric environment which allows for greater reactivity with the patient's blood. The total amount of ozone supplied to the blood and body in a typical “10- Pass” treatment is 140,000ug compared to the 3,000ug of ozone in the MAH method. This means that 10-Pass ozone supplies nearly 50 times the amount of Ozone to the body than regular intravenous Ozone treatment. The result is a treatment which administers a greater amount of ozone in a shorter amount of time, which in turn better saturates the red blood cells with oxygen and allows for deeper and greater penetration into the body.
The ground-breaking Hyperbaric 10 Pass method of administering ozone was pioneered by University Medical Doctor and PHD Dr. Johann Lahodny out of Austria. Extensive research and clinical application of the ‘10 pass’ system by Dr, Lahodny and others has yielded extraordinary results. This method is becoming the gold standard for medical ozone administration in Europe. Many individuals have been flying from North America to Europe to receive this treatment for a number of health concerns. According to Dr. Lahodny with 10 sessions of Hyperbaric Ozone therapy over the course of 10 weeks most ailments are repaired. This is a grand claim to make, considering the array of complex health conditions which afflict individuals in so many different ways, yet there is no question that Dr. Lahodny has been documenting a very high rate of successful patient outcomes across a multitude of diseases. Dr. Lahodny’s latest research, as to why High Dose 10 Pass ozone is having such excellent patient outcomes, has indicated that this treatment method is actually stimulating stem cell and ATP production within the body. This therapeutic benefit seems to be unique to High Dose 10 Pass therapy and is not seen in other methods of Ozone therapy.
The HiDose O3 Method
The HiDose O3 method is a form of intravenous ozone therapy developed by the Society of Progressive Medical Education (SOPMed). This method combines certain aspects of both MAH (Traditional IV Ozone therapy) and Hyperbaric ’10 Pass’ Ozone. The SOPMed HiDose O3 method differs from Hyperbaric ’10 Pass’ Ozone Therapy in that it does not use a hyperbaric ozone generating device and the blood is treated with ozone under regular atmospheric pressure. Furthermore, the HiDose O3 treatment method generally calls for treating only ‘1 pass’ of 200-300ml of blood, whereas the ‘10 pass’ method, as the name suggests, does multiple passes treating larger volumes of blood.
Where HiDose O3 is seen to be similar to the Hyperbaric method is in the much higher doses of ozone used to treat the patient’s blood. As stated before Traditional IV Ozone uses around 3000ug of ozone to treat about 200 ml of blood. Hyperbaric Ozone uses about 14,000ug of ozone to treat 200 ml of blood, and this is done 10 times. So, a total of 140,000ug of ozone is generally used to treat about 2000ml of blood. The HiDose O3 method uses around 70,000ug of ozone to treat 200-300ml of blood in a single pass. That is the equivalent to the amount of ozone used in 5 passes of hyperbaric ozone on the smaller volume of blood.
Additionally, the fact that the HiDose treatment requires only a single pass of blood can make this method a more appropriate treatment option for patients with compromised or weak vein structures.